Dernières publications scientifiques

  • Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.

  • Auteurs Modi S, Jacot W, Iwata H, Park YH, Vidal Losada M, Li W, Tsurutani J, Ueno NT, Zaman K, Prat A, Papazisis K, Rugo HS, Yamashita T, Harbeck N, Im SA, De Laurentiis M, Pierga JY, Wang X, Gombos A, Tokunaga E, Orbegoso Aguilar C, Yung L, Xiao F, Cheng Y, Cameron D
  • Revue Nat Med
  • Date de publication 2025-10
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.
  • In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers.

  • Auteurs Furgiuele S, Gevart T, Freis B, Ramirez MLA, Descamps G, Boutry S, Larbanoix L, Sant'Angelo D, Trelcat A, Saussez S, Bégin-Colin S, Journe F, Laurent S
  • Revue Nanoscale Adv
  • Date de publication 2025-10
In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers.
  • Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.

  • Auteurs Bergiers I, Köse MC, Skerget S, Malfait M, Fourneau N, Ellis JC, Vanhoof G, Smets T, Verbist B, De Maeyer D, Van Houdt J, Van der Borght K, Verona R, Heidrich B, Kurth W, Delforge M, Meuleman N, Van Droogenbroeck J, Vlummens P, Heuck CJ, Beguin Y, Bahlis N, Casneuf T, Caers J
  • Revue PLoS Genet
  • Date de publication 2025-10
Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.
  • The Cost-effectiveness of Mild Hypercapnia after Out-of-Hospital Cardiac Arrest: a Health Economic Evaluation alongside the TAME Study.

  • Auteurs Lee YY, Eastwood G, Bailey MJ, Bellomo R, Nichol AD, Parke RL, McGuinness S, Bernard S, Arabi YM, Capellier G, Chia YW, Grejs A, Hænggi M, Kutsogiannis D, Landoni G, Markota A, Nielsen N, Olasveengen T, Skrifvars MB, Taccone F, Wise MP, Higgins AM
  • Revue Resuscitation
  • Date de publication 2025-10
The Cost-effectiveness of Mild Hypercapnia after Out-of-Hospital Cardiac Arrest: a Health Economic Evaluation alongside the TAME Study.
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola